Smarter weapons to combat cancer
Yesterday, Bristol-Myers Squibb, the US pharmaceuticals group that specialises in cancer, launched a research drive to harness the growing knowledge of genes. The aim is to improve survival rates,
Yesterday, Bristol-Myers Squibb, the US pharmaceuticals group that specialises in cancer, launched a research drive to harness the growing knowledge of genes. The aim is to improve survival rates,